Media Summary: Featured speakers and panelists will provide Patient, Industry and Regulatory perspectives on clinical trial endpoints, modeling ... Rare Disease (RD) Consortia - Transplant Therapeutics Consortium (TTC): Presentation on how Rare Disease (RD) Consortia - Duchenne Regulatory Science Consortia (D-RSC): Presentation on modeling work surrounding ...

2022 Rdca Dap Workshop Case - Detailed Analysis & Overview

Featured speakers and panelists will provide Patient, Industry and Regulatory perspectives on clinical trial endpoints, modeling ... Rare Disease (RD) Consortia - Transplant Therapeutics Consortium (TTC): Presentation on how Rare Disease (RD) Consortia - Duchenne Regulatory Science Consortia (D-RSC): Presentation on modeling work surrounding ... Friedreich's Ataxia (FA) Modeling Project: Actional data resource of efficient data curation across data sources and looking ahead ... Centrality of Patient Advocacy Organizations in Accelerating Treatments for Rare Disease Speakers: Aliza Fink (NORD) and Ed ... Panelists: Theresa Mullin (FDA/CDER), Michelle Campbell (FDA/CDER), Billy Dunn (FDA/CDER), Pamela Gavin (NORD), ...

Speakers: Klaus Romero (C-Path) and Ed Neilan (NORD) Subscribe to C-Path Now ... Rare Disease (RD) Consortia - Critical Path for Sickle Cell Disease Consortium (CP-SCD): Presentation on how future ... Keynote Speaker: Theresa Mullin (FDA/CDER) Subscribe to C-Path Now ▻▻ The brief demonstration provides an overview of Critical Path Institute's Rare Disease Cures Accelerator-Data and Analytics ... Data Sharing and Analysis to Support Rare Disease Drug Development The European infrastructure for translational medicine, ...

Photo Gallery

2022 RDCA-DAP Workshop: Case Studies Panel Discussion and Q&A
2022 RDCA-DAP Workshop: Case Study 1, Transplant Therapeutics Consortium (TTC)
2022 RDCA-DAP Workshop: Case Study 3, Duchenne Regulatory Science Consortia (D-RSC)
2022 RDCA-DAP Workshop: Case Study 4: Friedreich’s Ataxia (FA) Modeling Project
2022 RDCA-DAP Workshop:  Future of RDCA-DAP and the Patient Voice
2022 RDCA-DAP Workshop: Centrality of Patient Advocacy Organizations in Accelerating Treatments
2022 RDCA-DAP Workshop: Impact of RDCA-DAP Panel Discussion
2022 RDCA-DAP Workshop: Opening Remarks
2022 RDCA-DAP Workshop: Case Study 2, Critical Path for Sickle Cell Disease Consortium (CP-SCD)
2022 RDCA-DAP Workshop: Keynote
RDCA-DAP Demonstration
Sharing Data With RDCA-DAP: Your Questions Answered
View Detailed Profile
2022 RDCA-DAP Workshop: Case Studies Panel Discussion and Q&A

2022 RDCA-DAP Workshop: Case Studies Panel Discussion and Q&A

Featured speakers and panelists will provide Patient, Industry and Regulatory perspectives on clinical trial endpoints, modeling ...

2022 RDCA-DAP Workshop: Case Study 1, Transplant Therapeutics Consortium (TTC)

2022 RDCA-DAP Workshop: Case Study 1, Transplant Therapeutics Consortium (TTC)

Rare Disease (RD) Consortia - Transplant Therapeutics Consortium (TTC): Presentation on how

2022 RDCA-DAP Workshop: Case Study 3, Duchenne Regulatory Science Consortia (D-RSC)

2022 RDCA-DAP Workshop: Case Study 3, Duchenne Regulatory Science Consortia (D-RSC)

Rare Disease (RD) Consortia - Duchenne Regulatory Science Consortia (D-RSC): Presentation on modeling work surrounding ...

2022 RDCA-DAP Workshop: Case Study 4: Friedreich’s Ataxia (FA) Modeling Project

2022 RDCA-DAP Workshop: Case Study 4: Friedreich’s Ataxia (FA) Modeling Project

Friedreich's Ataxia (FA) Modeling Project: Actional data resource of efficient data curation across data sources and looking ahead ...

2022 RDCA-DAP Workshop:  Future of RDCA-DAP and the Patient Voice

2022 RDCA-DAP Workshop: Future of RDCA-DAP and the Patient Voice

Presentation(s)/Discussion on

2022 RDCA-DAP Workshop: Centrality of Patient Advocacy Organizations in Accelerating Treatments

2022 RDCA-DAP Workshop: Centrality of Patient Advocacy Organizations in Accelerating Treatments

Centrality of Patient Advocacy Organizations in Accelerating Treatments for Rare Disease Speakers: Aliza Fink (NORD) and Ed ...

2022 RDCA-DAP Workshop: Impact of RDCA-DAP Panel Discussion

2022 RDCA-DAP Workshop: Impact of RDCA-DAP Panel Discussion

Panelists: Theresa Mullin (FDA/CDER), Michelle Campbell (FDA/CDER), Billy Dunn (FDA/CDER), Pamela Gavin (NORD), ...

2022 RDCA-DAP Workshop: Opening Remarks

2022 RDCA-DAP Workshop: Opening Remarks

Speakers: Klaus Romero (C-Path) and Ed Neilan (NORD) Subscribe to C-Path Now ...

2022 RDCA-DAP Workshop: Case Study 2, Critical Path for Sickle Cell Disease Consortium (CP-SCD)

2022 RDCA-DAP Workshop: Case Study 2, Critical Path for Sickle Cell Disease Consortium (CP-SCD)

Rare Disease (RD) Consortia - Critical Path for Sickle Cell Disease Consortium (CP-SCD): Presentation on how future ...

2022 RDCA-DAP Workshop: Keynote

2022 RDCA-DAP Workshop: Keynote

Keynote Speaker: Theresa Mullin (FDA/CDER) Subscribe to C-Path Now ▻▻ https://www.youtube.com/c/CriticalPathInstitute ...

RDCA-DAP Demonstration

RDCA-DAP Demonstration

The brief demonstration provides an overview of Critical Path Institute's Rare Disease Cures Accelerator-Data and Analytics ...

Sharing Data With RDCA-DAP: Your Questions Answered

Sharing Data With RDCA-DAP: Your Questions Answered

Learn more: https://rarediseases.org/

Webinar: RDCA-DAP and EATRIS Present Rare Disease Drug Development

Webinar: RDCA-DAP and EATRIS Present Rare Disease Drug Development

Data Sharing and Analysis to Support Rare Disease Drug Development The European infrastructure for translational medicine, ...